Oriental Trimex Limited has announced its unaudited financial results for the third quarter of FY26 ended December 31, 2025, alongside a significant corporate development involving fundraising through Foreign Currency Convertible Bonds. The company's Board of Directors convened on February 12, 2026, to approve the quarterly results and strategic funding initiatives.

Financial Performance Highlights

The company demonstrated strong operational growth during Q3FY26, with several key performance indicators showing positive momentum:

The company's revenue from operations surged to ₹331.06 lacs in Q3FY26, representing a substantial 76.52% increase from ₹187.53 lacs in the corresponding quarter of the previous year. However, net profit declined to ₹10.98 lacs compared to ₹426.18 lacs in Q3FY25, primarily due to the absence of exceptional items that had significantly boosted profits in the previous year.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Oriental Trimex reported comprehensive financial metrics:

The nine-month results showcase sustained revenue growth, with total revenue more than doubling to ₹1,050.26 lacs from ₹507.64 lacs in the corresponding period last year.

Major Corporate Development: FCCB Fundraising

In a significant strategic move, the Board of Directors approved a proposal to raise funds through Foreign Currency Convertible Bonds (FCCBs):

The board has authorized the newly constituted FCCB Committee to finalize terms and conditions of the bond issuance and undertake all necessary procedural requirements. The committee is also empowered to appoint agencies, intermediaries, advisors, and other professionals required for the proposed issuance.

Operational Metrics and Cost Structure

The company's cost structure during Q3FY26 reflected operational adjustments, with total expenses of ₹316.35 lacs compared to ₹367.44 lacs in Q3FY25. Key expense components included cost of materials consumed at ₹288.69 lacs and purchases of stock-in-trade at ₹147.40 lacs. The company maintained its paid-up equity share capital at ₹7,350.73 lacs throughout the reporting periods.

Regulatory Compliance and Governance

The financial results were reviewed by the Audit Committee and subsequently approved by the Board of Directors during their meeting held on February 12, 2026. The results comply with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and have been subject to limited review by independent auditors Aditya S Jain and Company, Chartered Accountants.

Oriental Trimex Limited has announced a board meeting scheduled for February 12, 2026, to deliberate on key financial matters and strategic funding initiatives. The meeting, set to commence at 01:00 PM at the company's registered office, will address critical business decisions as the company progresses through the current financial year.

Board Meeting Agenda

The board meeting has been convened to address several important matters that will shape the company's financial trajectory. The primary agenda items demonstrate the company's focus on both financial transparency and growth capital optimization.

Financial Results Consideration

The board will consider and approve the unaudited financial results for the quarter ended December 31, 2025, marking the third quarter of FY26. This quarterly review represents a crucial milestone in the company's financial reporting cycle and will provide stakeholders with insights into the company's operational performance during this period.

Fund Raising Strategic Options

A significant portion of the board meeting will be dedicated to discussing and considering various fund raising options. The company is exploring multiple financing avenues to address its increasing growth capital requirements. The strategic options under consideration include equity financing, debt instruments, or hybrid financial instruments, providing the board with flexibility to choose the most suitable funding mechanism based on market conditions and company requirements.

Trading Window Reopening

In compliance with regulatory requirements, Oriental Trimex Limited has announced that the trading window for equity shares will reopen on February 15, 2026. This reopening will apply to all designated persons of the company, ensuring adherence to SEBI regulations regarding insider trading restrictions.

The announcement reflects the company's commitment to maintaining transparency and regulatory compliance while pursuing strategic growth initiatives through appropriate funding mechanisms.